RHOA and breast cancer: In BC cells, p66Shc drives redox signalling pathways via interaction with alpha‐1‐syntrophin (SNTA1) and Grb2 that facilitate tumour cell migration by activating the RhoA GTPase (regulator of cytoskeletal dynamics) [1, 3].